Patent Assignment
Reel/Frame 026069/0965
Assignment of Assignor's Interest
Recorded: 2011-04-04
Pages: 3
Assignor
INFIGEN, INC.
Executed: 2007-02-01
Assignee
ADVANCED CELL TECHNOLOGY, INC.
33 LOCKE DR, MARLBOROUGH, MASSACHUSETTS, 01752
Covered Property
(1)
In Vitro Activation of Mammalian Oocytes
Patent:
6,680,199 →
Application:
09/576,592 →
Related Assignments
(11)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
May 31, 2002
From: HANCOCK LIFE INSURANCE COMPANY; INVESTORS PARTNER LIFE INSURANCE COMPANY; MASSACHUSETTS MUTUAL LIFE INSURANCE COMPANY; MASSMUTUAL CORPORATE VALUE PARTNERS, LTD.
To: INFIGEN, INC.; DEPARTMENT OF COMMERCE, WISCONSIN
Reel/Frame 012947/0331 →
Assignment of Assignor's Interest
Jun 13, 2005
From: WISCONSIN DEPARTMENT OF COMMERCE
To: INFIGEN, INC.
Reel/Frame 016127/0001 →
Grant of a Security Interest in Grantor's (Debtor'
Feb 27, 2006
From: PHARMING GROUP N.V.
To: KING GEORGE HOLDINGS LUXEMBOURG IIA S.A.R.L.
Reel/Frame 017223/0001 →
License
Mar 2, 2006
From: INFIGEN, INC.
To: PHARMING GROUP N.V.
Reel/Frame 017240/0454 →
Release of Security Interest
Feb 23, 2010
From: PHARMING GROUP N.V.
To: KING GEORGE HOLDINGS LUXEMBOURG IIA S.A.R.L.
Reel/Frame 023973/0415 →
Corrective Assignment to Correct the Nature of Conveyance, Assignor and Assignee Previously Recorded on Reel 023973 Frame 0415. Assignor(S) Hereby Confirms the Release of Security Interest.
Mar 10, 2010
From: KING GEORGE HOLDINGS LUXEMBOURG IIA S.A.R.L.
To: PHARMING GROUP N.V.
Reel/Frame 024079/0924 →
Security Agreement
Jan 25, 2013
From: ADVANCED CELL TECHNOLOGY, INC.; MYTOGEN, INC.
To: CAMOFI MASTER LDC; CAMHZN MASTER LDC
Reel/Frame 029698/0001 →
Release of Security Interest
Nov 24, 2014
From: CAMOFI MASTER LDC; CAMHZN MASTER LDC
To: ADVANCED CELL TECHNOLOGY, INC.; MYTOGEN, INC.
Reel/Frame 034421/0863 →
Security Interest
Dec 7, 2016
From: PHARMING GROUP N.V.
To: SILICON VALLEY BANK
Reel/Frame 040594/0031 →
Amended and Restated Intellectual Property Security Agreement
May 16, 2017
From: PHARMING GROUP N.V.
To: ORBIMED ROYALTY OPPORTUNITIES II, LP
Reel/Frame 042481/0051 →
Release of Security Interest
Jan 28, 2020
From: ORBIMED ROYALTY OPPORTUNITIES II, LP
To: PHARMING GROUP N.V.; PHARMING TECHNOLOGIES B.V.; PHARMING INTELLECTUAL PROPERTY B.V.; BROEKMAN INSTITUUT B.V.
Reel/Frame 051722/0304 →